期刊文献+

铸骨冲剂对维甲酸致大鼠实验性骨质疏松症的影响

EFFECT OF ZHUGU CHONGJI ON EXPERIMENTAL OSTEOPROSIS CAUSED BY TRETINOIN IN RAT
暂未订购
导出
摘要 目的: 探讨中药复方铸骨冲剂对实验性骨质疏松症的防治作用。方法: 采用维甲酸造成的大鼠实验性骨质疏松症模型, 研究了铸骨冲剂对实验大鼠血清生化及骨密度等指标的影响。结果: 铸骨冲剂158 g/kg , 316 g/kg 能明显增强血清碱性磷酸酶的活性( P< 001 , P< 005) 、升高血清钙的浓度 ( P< 005 , P< 001) , 降低尿羟脯氨酸/ 尿肌酐的比值 ( 均 P< 001) , 防止骨密度的降低 ( P< 001 , P< 005) 和骨骼中钙 ( P< 001 , P< 005) 、磷 ( 均 P< 005) 元素含量的降低。结论: 铸骨冲剂能在一定程度上抑制骨吸收, 促进骨形成, 对实验性骨质疏松症具有明显的防治作用。 Objective:To investigate the prevention and cure of experimental osteoporosis by compound Chinese drugs Zhugu Chongji.Methods:With the model of experimental osteoporosis caused by tretinoin,we studied Zhugu Chongji's effects on serium biochemistry and bone mineral density results of experimental rats.Results: Zhugu Chongji(1 58g/kg,3 16g/kg) can significantly increase the activity of serium alkaline phosphatase( P <0 01, P <0 05) and the concentration of blood calcium( P <0 05, P <0 01),while they decrease urine hydroxyproline urine creatinine ratio(both P <0 01).It can also prevent against the decrease of bone mineral density( P <0 01, P <0 05) and calcium( P <0 01, P <0 05),phosphorus(both P <0 05) content in bones. Conclusion:Zhugu Chongji can reduce bone absorption and promote osteosis to some extent.It can significantly prevent and cure experimental osteoporosis.
出处 《中日友好医院学报》 1999年第4期191-194,共4页 Journal of China-Japan Friendship Hospital
基金 国家教委博士学科点专项科究基金
关键词 大鼠 中草药 维甲酸 骨质疏松 药理 rats drugs,Chinese herbal tretinoin osteoporosis
  • 相关文献

参考文献6

二级参考文献8

  • 1李青南,中国药理学报,1994年,15卷,528页
  • 2朱学骏,实用皮肤性病治疗学,1992年
  • 3邵金莺,中药药理与临床,1989年,5卷,25页
  • 4王士凡,药物不良反应,1988年
  • 5Eden J,美国医学会杂志,1996年,15卷,47页
  • 6C. Hasling MD,P. Charles1,F. T?geh?j Jensen,L. Mosekilde. A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis[J] 1994,Osteoporosis International(4):191~203
  • 7H. Orimo,M. Shiraki,Y. Hayashi,T. Hoshino,T. Onaya,S. Miyazaki,H. Kurosawa,T. Nakamura,N. Ogawa. Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis[J] 1994,Calcified Tissue International(5):370~376
  • 8M. Kleerekoper M.D.,E. L. Peterson,D. A. Nelson,E. Phillips,M. A. Schork,B. C. Tilley,A. M. Parfitt. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis[J] 1991,Osteoporosis International(3):155~161

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部